|
Volumn 9, Issue 5, 2002, Pages 1107-1113
|
Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOPURINOL;
ANTIPROTOZOAL AGENT;
BENZNIDAZOLE;
BW 349C59;
FLUORESCEIN ISOTHIOCYANATE;
IMMUNOGLOBULIN G ANTIBODY;
NIFURTIMOX;
PROTOZOON ANTIBODY;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHAGAS DISEASE;
CHEMOTHERAPY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
EVALUATION;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
INFANT;
MALE;
MONITORING;
PRIORITY JOURNAL;
SEROLOGY;
TRYPOMASTIGOTE;
VALIDATION PROCESS;
XENODIAGNOSIS;
ADOLESCENT;
ADULT;
AGED;
ANIMALS;
ANTIBODIES, PROTOZOAN;
CHAGAS DISEASE;
CHILD;
CHILD, PRESCHOOL;
CRYOPROTECTIVE AGENTS;
DOUBLE-BLIND METHOD;
EVALUATION STUDIES;
FEMALE;
FLOW CYTOMETRY;
GLYCEROL;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
TEMPERATURE;
TRYPANOSOMA CRUZI;
|
EID: 0036733671
PISSN: 1071412X
EISSN: None
Source Type: Journal
DOI: 10.1128/CDLI.9.5.1107-1113.2002 Document Type: Article |
Times cited : (26)
|
References (20)
|